The clinical impact of ROMA is significant in guiding the management of ovarian masses. By providing a clearer risk profile, ROMA aids in clinical decision-making, helping to determine whether a patient should be referred to a gynecologic oncologist or managed conservatively. This can lead to earlier detection of ovarian cancer in high-risk patients and avoid unnecessary interventions in low-risk patients.
